Dedicated to speeding up the development of a safe, powerful, accessible, preventive HIV vaccine, the International AIDS Vaccine Initiative (IAVI) initiated methods of addressing the insufficient incentive arrangements that prevented advancement toward vaccines for AIDS and other diseases predominantly affecting poor people in tropical nations. As an mediator nonprofit association, IAVI brought together associates from nonprofit, business, government and scientific research sectors with different viewpoints and motivations toward developing vaccines.
IAVI played several parts: communicator and honest agent, integrator of knowledge regarding AIDS vaccine research, enthusiastic advocate for AIDS vaccines at national and international levels, and coordinator and manager of research and development initiatives. In 2008, IAVI invested in its own laboratories and research infrastructure, moving in vaccine development partnerships and clinical research. How should IAVI manage tensions between what is needed to construct new incentive structures that enable key actors to work together efficiently and what is crucial to realize its mission?
PUBLICATION DATE: November 04, 2009 PRODUCT #: 310015-PDF-ENG
This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE
Related Case Solutions & Analyses:
Back Office Cooperative
Revitalize Your Mature Company to Sustain Market Leadership
Harmonizing Demand Forecasting and Supply at Mahindra & Mahindra Ltd.
The Hong Kong Blind Union: A Small Self-help NGO With Board Of Directors Actively Involved In Operation
Apple (in 2013): How to Sustain a Competitive Advantage?
Maria Gonzalez
Beidahuang
Note on Directors’ Duties and Obligations Under Canadian Law and Custom
The Iraq War Case
Hotel-Dieu de France: The Deployment and Improvement of a Disaster Relief Plan
